Page 71 - product-manual

TM/MC TM/MC
REFERENCES (cont’d)

Lascelles BD, DePuy V, Thomson A, et al. (2010). Evaluation of a therapeutic diet for feline degenerative joint disease. Journal of Veterinary Internal Medicine. 24:487-95.

Li X. (2002). Chinese Materia Medica: Combinations and Applications. Donica Publications.

McCarthy G, O’Donovan J, Jones B, et al. (2007). Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the
treatment of dogs with osteoarthritis. Veterinary Journal. 174:54-61.

Monfort J,Nacher M,Montell E, et al. (2005). Chondroitin sulfate and hyaluronic acid (500-730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritis chondrocytes.
Drugs Under Experimental and Clinical Research. 31:71-76.

Occhiuto F, Circosta C, Raqusa S, et.al. (1985). A drug used in Traditional Medicine: Harpagophytum procumbens. Effects on some isolated muscle preparations. Journal of
Ethnopharmacology. 13:201-8.

Pal A, Bawankule DU, Darokar MP, et al. (2011). Influence of Moringa oleifera on pharmacokinetic disposition of rifampicin using HPLC-PDA method: a pre-clinical study.
Biomedical Chromatography. 25:641-5.

Paliwal R, Sharma V. Pracheta, et al. (2011). Anti-nephrotoxic effect of administration of Moringa oleifera Lam in amelioration of DMBA-induced renal carcinogenesis in
Swiss albino mice. Biology and Medicine. 3SI:27-35.

Penolazzi L, Lampronti I, Borgatti M, et al. (2008). Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis.
BMC Complementary and Alternative Medicine. 8:59.

Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, et al. (2008). Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with
conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World Journal of Gastroenterology. 14:1491-7.

Reichling J, Schmökel H, Fitzi J, et al. (2004). Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweizer Archiv fur Tierheilkunde.
146:71-9.

Safayhi H, Rall B, Sailer ER, Ammon HP. (1997). Inhibition by boswellic acids of human leukocyte elastase. The Journal of Pharmacology and Experimental Therapeutics.
281:460-3.

Sashidhara KV, Rosaiah JN, Tyagi E, et al. (2009). Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive
agents. European Journal of Medicinal Chemistry. 44:432-6.

Senin P, Makovec F, Rovati L. (1987). Stable compounds of glucosamine sulphate. United States Patent 4,642,340; 1987. Accessed: November 30, 2011. Available at: http://
patents.justia.com/1987/04642340.html

Siemoneit U, Pergola C, Jazzar B, et al. (2009). On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
European Journal of Pharmacology. 606:246-54.

Singh GB, Atal CK. (1986). Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new nonsteroidal anti-inflammatory agent. Agents and Actions. 18:407-412.

Stargrove MB, Treasure J, McKee DL. (2008). Herb, Nutrient, and Drug Interactions. Clinical Implications and Therapeutic Strategies. Missouri (USA): Mosby Elsevier.

Sumantran VN, Kulkarni A, Chandwaskar R, et al. (2008). Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis.
Evidence- Based Complementary Alternative Medicine. 5:329-335.

Tai J, Cheung S. (2007). Anti-proliferative and antioxidant activities of Saposhnikovia divaricata. Oncology Reports. 18:227-34.

10 | Articulare-VM TM